Related references
Note: Only part of the references are listed.Clinical delineation, sex differences, and genotype-phenotype correlation in pathogenic KDM6A variants causing X-linked Kabuki syndrome type 2
Victor Faundes et al.
GENETICS IN MEDICINE (2021)
Pasireotide treatment for severe congenital hyper-insulinism due to a homozygous ABCC8 mutation
Christiaan F. Mooij et al.
ANNALS OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2021)
Diazoxide for the Treatment of Transitional Neonatal Hypoglycemia: A Systematic Review
Don Laing et al.
Journal of Neonatology (2021)
The danger of diazoxide in the neonatal intensive care unit
Jay Desai et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2021)
Hyperinsulinemic hypoglycemia in children and adolescents: Recent advances in understanding of pathophysiology and management
Maria Guemes et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2020)
Comparative meta-analysis of Kabuki syndrome with and without hyperinsulinaemic hypoglycaemia
Henrike Hoermann et al.
CLINICAL ENDOCRINOLOGY (2020)
Congenital hyperinsulinism as the presenting feature of Kabuki syndrome: clinical and molecular characterization of 10 affected individuals
Kai Lee Yap et al.
GENETICS IN MEDICINE (2019)
The Genetic and Molecular Mechanisms of Congenital Hyperinsulinism
Sonya Galcheva et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Current and Emerging Agents for the Treatment of Hypoglycemia in Patients with Congenital Hyperinsulinism
Ana Paola De Cosio et al.
PEDIATRIC DRUGS (2019)
Diazoxide-induced pulmonary hypertension in hyperinsulinaemic hypoglycaemia: Recommendations from a multicentre study in the United Kingdom
Suet Ching Chen et al.
CLINICAL ENDOCRINOLOGY (2019)
Kabuki syndrome: review of the clinical features, diagnosis and epigenetic mechanisms
Yi-Rou Wang et al.
WORLD JOURNAL OF PEDIATRICS (2019)
A Multicenter Experience with Long-Acting Somatostatin Analogues in Patients with Congenital Hyperinsulinism
Ivo van der Steen et al.
HORMONE RESEARCH IN PAEDIATRICS (2018)
Hyperinsulinism in the Neonate
Katherine Lord et al.
CLINICS IN PERINATOLOGY (2018)
Congenital Hyperinsulinism in Infants with Turner Syndrome: Possible Association with Monosomy X and KDM6A Haploinsufficiency
Christopher E. Gibson et al.
HORMONE RESEARCH IN PAEDIATRICS (2018)
Unraveling molecular pathways shared by Kabuki and Kabuki-like syndromes
C. Lintas et al.
CLINICAL GENETICS (2018)
Hyperinsulinemic hypoglycemia in Beckwith-Wiedemann, Sotos, and Kabuki syndromes: A nationwide survey in Japan
Naoko Toda et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2017)
Congenital Hypoglycemia Disorders: New Aspects of Etiology, Diagnosis, Treatment and Outcomes
Diva D. De Leon et al.
PEDIATRIC DIABETES (2017)
Treatment with long-acting lanreotide autogel in early infancy in patients with severe neonatal hyperinsulinism
Heike Corda et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Functional and Metabolomic Consequences of KATP Channel Inactivation in Human Islets
Changhong Li et al.
DIABETES (2017)
Novel KDM6A (UTX) mutations and a clinical and molecular review of the X-linked Kabuki syndrome (KS2)
S. Banka et al.
CLINICAL GENETICS (2015)
Molecular Analysis, Pathogenic Mechanisms, and Readthrough Therapy on a Large Cohort of Kabuki Syndrome Patients
Lucia Micale et al.
HUMAN MUTATION (2014)
How genetically heterogeneous is Kabuki syndrome?: MLL2 testing in 116 patients, review and analyses of mutation and phenotypic spectrum
Siddharth Banka et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2012)
Effects of lanreotide, a somatostatin analogue, on postprandial gastric functions and biliopancreatic secretions in humans
A. Lamrani et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Long-acting octreotide and prolonged-release lanreotide formulations have different pharmacokinetic profiles
B Astruc et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Atypical findings in Kabuki syndrome:: Report of 8 patients in a series of 20 and review of the literature
D Geneviève et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2004)
Share Paper
